Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by newdaydawningon Feb 24, 2019 8:58pm

198 Views

Post# 29407002

Single treatment, minimal side effects, cancer gone

Does it get any better? Please correct me if I'm wrong, but I am unaware of any other form of cancer therapy that achieves 1-year CR with a single treatment. What TLT is demonstrating is truly disruptive and unstoppable.

For those who have patience, imagine where TLT will be in four years time, assuming it hasn't been sold for 10 to 20 times its current value. The longer Theralase maintains its independence, the greater the return for shareholders.

Bullboard Posts

Transportation technology stock secures second major contract in a week